This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Respiratory Inhaler Devices Market

Market Insights on Respiratory Inhaler Devices covering sales outlook, demand forecast & up-to-date key trends

Respiratory Inhaler Devices Market by Product (Dry Powder Inhalers, Metered Dose Inhalers, Nebulizers), Technology (Manually Operated Inhaler Devices, Digitally Operated Inhaler Devices), Disease Indication (Asthma, Chronic Obstructive Pulmonary Disease, Pulmonary Arterial Hypertension, Others), End User & Region - Forecast to 2021 - 2031

Respiratory Inhaler Devices Market - About the Report

[250 Pages Report] The rising prevalence of respiratory disorders has necessitated innovation in manufacture of respiratory inhalers. The demand for better precision in drug delivery is enabling broader adoption of Respiratory Inhaler Devices, especially among patients of asthma and chronic obstructive pulmonary diseases (COPD). Steady growth is expected to continue as favorable reimbursement policies by governments create a conducive environment around the world.

In its new study, ESOMAR-certified market research and consulting firm Future Market Insights (FMI) offers insights about key factors driving demand for respiratory inhalers. The report tracks the global sales of respiratory inhalers in 20+ high-growth markets, along with analyzing the impact COVID-19 has had on the medical device industry in general, and Respiratory Inhaler Devices in particular.

Customize this Report

Let us know your requirement to get
100% FREE customization

Historical and Future Outlook

Chronic obstructive pulmonary diseases (COPD) represent a major health concern and have been reported by the World Health Organization (WHO) as one of the leading causes of death. Pharmaceutical drugs and effective medical devices have remained key to management of COPD and other respiratory diseases.

For instance, Sustainable Development Goals (SDG) created by the United Nations in 2016 were intended at improving living standard globally. Likewise, the Forum of International Respiratory Societies (FIRS) was a part of a worldwide call for action to address the soaring burdens of respiratory diseases. These efforts have been crucial in driving demand for respiratory inhalers. According to FMI’s analysis, respiratory inhaler sales have grown at 3.4% CAGR between 2015 and 2019.

A slew of new drugs were launched for the management of asthma and COPD over the last decade and development of more are currently underway. With leading drug manufacturers expecting the demand to surge amid COVID-19, respiratory inhaler sales are set to grow steadily through 2030.

The pandemic crisis has resulted in the fast-tracking of drug approval, a trend most welcome by drug manufacturers. In a statement the U.S. Food and Drug Administration (USFDA) has recognized the surging demand for albuterol products amid pandemic crisis. The organization also reiterated its commitment to facilitating access to medical products in the statement. These developments present a positive outlook for growth. FMI expects global respiratory inhalers market to grow at 4.4% CAGR through 2030.

Will Combination Therapies Influence Respiratory Inhaler Demand?

The adoption of combination therapies for treatment of COPD and asthma has grown steadily. The rising adoption of combination therapies such as triple combination therapy is a favorable factor for Respiratory Inhaler Devices market.

Precision in drug delivery is imperative for these therapies to be effective and inhaler devices are considered as the most efficient medium enabling accurate dosage of drugs. Combination therapies are considered reliable source of treatment for complex patients. Besides this, favorable reimbursement policies have been encouraging adoption of the Respiratory Inhaler Devices.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

What is the Commercial Potential of Smart Inhaler Technology?

A report, titled “Smart Asthma” published in 2017, Asthma U.K. highlighted concerns pertaining to the need for health systems to plan well in advance so that full potential of smart inhaler technology can be realized. With several companies prioritizing the launch of smart inhaler devices, growth opportunities seem impressive. Positive results from studies conducted on smart inhaler devices and applications trials have piqued the interest of some of the leading pharmaceutical companies.

Boehringer Ingelheim, Novartis, and GlaxoSmithKline have signed development deals with Propeller Health, while AstraZeneca has entered into a master supply agreement with Adherium.

Why R&D is Key to Market Consolidation?

Some of the leading companies are investing in research and development to gain competitive advantage. For instance, CIPLA is currently investigating across resources in the U.S. to expand its franchise. Besides this, it already has completed the phase 3 trial of g-Advair and is waiting to subsequently file for USFDA approval. With companies around the world increasingly focusing on research initiatives, expansion is on card.

Inhaler medication continues to remain a cornerstone for administering treatment to patients with respiratory disorders. The benefits of respiratory inhalation therapies have long been identified. With the demand for more efficient delivery systems rising, the focus on research and development will increase.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

What is the Regulatory Impact on Global Sales?

The World Health Organization has forecast COPD to become the third leading cause of death around the world by 2025. The rising incidence of respiratory ailments and the increasing demand for effective treatment has been creating lucrative opportunities for growth. With the implementation of conducive reimbursement policies, the Respiratory Inhaler Devices market is expected to gain significant impetus in the coming years.

Improvements in standard healthcare policies and rising focus towards making advanced treatment better accessible will create lucrative growth prospects for Respiratory Inhaler Devices market. For instance, the implementation of the Affordable Care Act helped nearly forty million uninsured Americans gain access to healthcare services.

Likewise, health services are largely free in England. The National Health Service (NHS) provides primary care, preventive medicines, and hospital services to “ordinarily resident” in the country. From 2018, radical changes were introduced in NHS that will allow social care leaders to formally devise care for individual patients, which will be increasingly made available away from hospitals. These developments aimed at making healthcare better accessible will present a conducive environment for respiratory inhalers sales.

Similarly, Japan’s universal healthcare system is known for keeping its population healthy at an exceptionally low cost. According to OCED, Japan’s healthcare reform focuses on controlling costs, while improving the quality of care. Presence of favorable regulatory environment will continue bolstering sales prospects through the forecast period.

Country-wise Insights

How Big is the Opportunity in US?

FMI has projected North America to remain one of the most lucrative Respiratory Inhaler Devices markets throughout the course of the forecast period. One of the key factors supporting expansion is the region’s high healthcare spending. According to preliminary forecasts by CMS’ Office of the Actuary, the overall healthcare spending in the United States alone is likely to increase at 5.4% between 2019 and 2028, outpacing the country’s GDP by 4.3%.

Furthermore, the U.S. remains one of the largest Respiratory Inhaler Devices markets for medical devices in the world, which invariably makes it a lucrative pocket for respiratory inhaler devices manufacturers. According to SelectUSA the medical devices market in the U.S. accounted for 40% of the global Respiratory Inhaler Devices market in 2017. By 2023, it is expected to reach US$203 billion. As per the Centers for Medicare & Medicaid Services (CMS), retail spending for durable medical equipment in the U.S. stood at US$54.4 billion in 2017. It is projected to increase in the coming years, which is indicative of remarkable scope for expansion it will offer to respiratory inhaler devices companies.

Favorable healthcare policies, coupled with high per capita healthcare spending, has created a conducive environment for the adoption of respiratory inhaler devices in the U.S. Also the presence of leading players such as Merck & Co. is supporting growth in the U.S. Strategies undertaken by these companies include product launches and expansion plans, which will continue aiding overall expansion in the U.S.

UK’s Medical Device Sales Need Revival

The adoption of respiratory inhalers devices is expected to rise considerably across hospitals and healthcare facilities in countries across UK. As a result of efforts by various government organizations such as the European Academy of Allergy & Clinical Immunology to spread awareness about COPD and asthma, the demand for respiratory inhaler devices is expected to surge. Europe is identified by FMI as the second-leading Respiratory Inhaler Devices market, a position it is likely to hold on to through the forecast period.

Respiratory Inhaler Devices Market Download Report Brochure

According to a research by the University of Edinburgh COPD care costs in England is likely to exceed £2.5bn by 2030. This is indicative of rising health expenditure on treatment of respiratory ailments, which represents scope for the expansion in the U.K. According to the Organization for Economic Co-operation and Development, U.K. spent nearly £2,989 per person on healthcare in 2017. With healthcare spending in the U.K. forecast to surge significantly, sales prospects are likely to get better.

Why Innovation is Key to Succeed in German Medical Device Market?

The Federal Statistical Office has reported that healthcare spending in Germany rose by 4% in 2018 from 2017. In 2018, the country’s healthcare spending accounted for 11.7% of the GDP. Furthermore, health expenditure was expected to surge to 407.4 billion Euros by 2019, presenting a lucrative landscape for the expansion of the respiratory inhaler devices.

Also presence of companies such as Boehringer Ingelheim GmbH is supporting the expansion in Germany. The company has launched Respimat® inhaler in Germany in April 2020. Besides this, the company has been investing significantly in expansion efforts. Growth strategies adopted by these companies are expected to aid the expansion in Germany.

Since 2009, health insurance has been made mandatory for all citizens of the country. According to NCBI, a total of 70 million people, which roughly covers 85% of the population are covered by statutory health insurance. Another 11% population of Germany is covered by substitutive private health insurance. Conducive reimbursement policies and regulatory scenario are presenting attractive opportunities for growth.  

Sales in France Tied Closely to Healthcare Spending

According to the National Center for Biotechnology Information (NCBI), French survey results showed that COPD patients required considerable use of healthcare resources, with annual direct cost incurred, estimated to be at Euro 530 per patient. Additionally, another survey by NCBI revealed that prevalence of severe asthma was estimated to be around 0.18% to 0.51% among French adults. The high burden of respiratory disease in France is leading to increasing demand for effective treatment measures. The demand for respiratory inhaler devices is therefore expected to remain considerably high in the country.

Healthcare spending in France stood nearly at 11.25% of the GDP in 2018 as per the World Bank. While this represented a slight decline than healthcare spending of previous year, the position of healthcare continues to remain that of national responsibility in the country. Coupled with favorable government policies, a surging incidence of respiratory illnesses will keep the demand for respiratory inhaler devices high in France.

Growing COPD Prevalence in China to Create a Surge

While US and Europe will continue leading, growth in South Asia is expected to happen at an accelerated pace. According to the World Health Organization, 3 million people around the world died of COPD in 2012 and 90% of COPD deaths were recorded in low and middle income countries, including China.

A nationwide survey conducted in China revealed that prevalence of COPD among people aged 40 years and above was 8.2% in 2008. Based on results revealed in the Global Burden of Disease Study, COPD was third-leading cause of death in the country in 2010. These figures are indicative of opportunities for wider penetration in China, subsequently South Asia.

What’s the Market Share of Dry Inhalers?

The dry powder inhaler (DPI) segment will continue accounting for over half of the global share among products through the forecast period. According to FMI, the segment is expected to hold a little below 54% of the market, in terms of product type, by the end of 2030. Dry powder inhalers offer greater precision and straightforward usage, which are the leading causes behind dominance of the segment.

Convenient mechanism of DPIs is enabling their uptake for drug delivery in COPD and asthma treatment. However, in the coming years an increasing number of patients are likely to switch to metered dose inhalers on grounds of improved disease control and reduced exacerbations.

Why Manual Inhaler Devices Hold 90% Share?

Accounting for over 90% of the overall share through the forecast period, manually operated inhaler devices continue to account for bulk of demand. Growth in the digitally operated inhaler devices segment is likely to , primarily because the technology is still at a nascent stage and is yet to become widespread.

The primary aim of manually operated inhaler devices is to optimize drug delivery to offer improved management of respiratory illnesses. The technology offers several advantages such as rapid onset of action, possibility of using precise doses of medication, and systematic absorption.

While experiments with digital inhalers are underway, manual inhalers remain widely sought-after. Experts are looking for ways to ensure that the technology adheres to correct disease management guidelines and eliminates the chances of miscalculations. Digital technologies have impressive growth prospects on card however lack of awareness could be withholding expansion of the segment to an extent.

Opportunities Abound in Asthma Treatment

According to FMI, the demand for respiratory inhaler devices will be higher for treatment of asthma. While the disease indication will continue leading, the COPD segment is expected to grow at an accelerated pace in the coming years. Besides this rising incidence of COPD, willingness surging healthcare expenditure around the world will aid the expansion of the segment.

According to the WHO, the Global Burden of Disease Study reported the prevalence of 251 million cases of COPD around the world in 2016. With the incidence of the disease forecast to rise, the demand from COPD segment is expected to surge at a higher pace in the coming years.

Competitive Landscape

Companies operating in the respiratory inhaler devices market are aiming at strategic collaborations with software and digital service providers to address the requirements of an expanding patient pool. For instance, Novartis has collaborated with leading U.S. mobile technology company Qualcomm to develop an integrated smart inhaler.

There is ample focus on innovations and USFDA approval among players. Besides aiming at competitive advantage, leading players are focusing on expanding their global footprint as they await approvals from international organizations. For instance, CIPLA’s Albuterol Sulfate MDI (g-Proventil) is its first device –based inhalation product to be approved by USFDA for sales across the U.S. In addition to this, the company has successfully completed Phase-3 clinical study of g-Advair, which is poised to help CIPLA expand its portfolio across the U.S.

Some of the players are focusing to carve a niche for specific demography. For instance, OMRON has launched WheezeScan device to aid treatment of asthma among children. This launch marks the company’s effort towards achieving its “Going For Zero” mission, under which it has pledged to work towards a world sans strokes or heart attacks.

Meanwhile, Lupin has launched a Bluetooth enabled-device with a built-in sensors to track the daily metered-dose inhaler usage and consumption pattern in patients. Through these developments, companies are aiming at competitive advantage. A slew of new launches are likely in the coming years.

Some of the leading companies operating in the market are:

  • AstraZeneca
  • Beximco Pharmaceuticals Ltd.
  • Boehringer Ingelheim GmbH
  • Cipla Ltd.
  • GlaxoSmithKline plc.
  • Koninklijke Philips N.V.
  • Merck & Co., Inc.
  • OMRON Healthcare Europe B.V.
  • PARI Medical Holding
  • Teva Pharmaceutical Industries Ltd.

*The list is not exhaustive, and only for representational purposes. Full competitive intelligence with SWOT analysis available in the report.

Scope of the Report

Attribute

Details

Forecast Period

2020-2030

Historical Data Available for

2016-2020

Market Analysis

USD Million for value and Units for Volume

Key Regions Covered

North America, Latin America, Europe, East Asia, South Asia, Oceania Middle East & Africa

Key Countries Covered

US, Canada, Germany, U.K., France, Italy, Spain, Poland, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Vietnam, Indonesia, Australia, New Zealand, GCC Countries, Turkey, Northern Africa, South Africa

Key Segments Covered

Product Type, Modality, Disease Indication, and Region

Key Companies Profiled

  • AstraZeneca
  • Beximco Pharmaceuticals Ltd.
  • Boehringer Ingelheim GmbH
  • Cipla Ltd.
  • GlaxoSmithKline plc.
  • Koninklijke Philips N.V.
  • Merck & Co., Inc.
  • OMRON Healthcare Europe B.V.
  • PARI Medical Holding
  • Teva Pharmaceutical Industries Ltd.

Report Coverage

Market Forecast, brand share analysis, competition intelligence, DROT analysis, Market Dynamics and Challenges, Strategic Growth Initiatives

Customization & Pricing

Available upon Request

Key Segments

Product

  • Dry Powder Inhalers
  •  Metered Dose Inhalers
  • Nebulizers
    • Compressed Air Nebulizers
    • Ultrasonic Nebulizers
    • Mesh Nebulizers

Technology

  • Manually Operated Inhaler Devices
  • Digitally Operated Inhaler Devices

Disease Indication

  • Asthma
  • Chronic Obstructive Pulmonary Disease
  • Pulmonary Arterial Hypertension
  • Others

Region

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Middle East and Africa (MEA)
  • Oceania

Frequently Asked Questions

US currently leads the global market for respiratory inhaler devices. Sales in US will be over 40% of total demand throughout the forecast period.

Dry powder inhalers are highly sought-after in every market. The demand for dry powder inhalers is expected to remain high in the near future, especially due to ease of usage and precision in drug delivery.

Manually operated inhaler devices continue to remain the leading choice among patients with respiratory ailments. While the availability of digitally operated devices is increasing, sales is likely to accelerate at a slower pace in comparison to the former.

Some of the leading companies offering respiratory inhaler devices are AstraZeneca, Beximco Pharmaceuticals Ltd., Boehringer Ingelheim GmbH, Cipla Ltd., GlaxoSmithKline plc., Koninklijke Philips N.V., Merck & Co., Inc., among others.

The World Health Organization has identified asthma as one of the major non-communicable diseases around the world. It also estimated that more than 339 million people had asthma globally in 2016. The rising incidence of asthma around the world is fuelling the demand for respiratory inhaler devices.

Table of Content

1.Executive Summary

    1.1. Market Overview

    1.2. Market Analysis

    1.3. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Key Market Trends

    3.1. Key Trends Impacting The Market

    3.2. Product Development Trends 

4. Market Background

    4.1. Macro-Economic Factors

        4.1.1. Transformation in Pricing Due to the Shift In Production to Emerging Economies

        4.1.2. Increasing Consumption Of Drugs To Pave Way For Pharma Research And Development

        4.1.3. Favorable Reimbursement Coverage and Increasing Per Capita Healthcare Expenditure

    4.2. Forecast Factors - Relevance & Impact

        4.2.1. Prevalence of Asthma

        4.2.2. Launch of New Products

        4.2.3. Adoption of Different Respiratory Inhaler Products

        4.2.4. Healthcare Expenditure

        4.2.5. Awareness Regarding Asthma & COPD 

        4.2.6. New Drug Development For COPD Treatment 

        4.2.7. Government and Private Organization Initiatives for Respiratory Disorder Treatment

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunity Analysis

5. COVID19 Crisis Impact Analysis

    5.1. Current COVID-19 Statistics and Probable Future Impact

    5.2. COVID19 and Impact Analysis

        5.2.1. Revenue By Product

        5.2.2. Revenue By Technology

        5.2.3. Revenue By Indication

        5.2.4. Revenue By Country

    5.3. 2020 Market Scenario

    5.4. Projected recovery Quarter

    5.5. Recovery Scenario - Short term, Midterm and Long Term Impact

6.  Market Context

    6.1. Key Epidemiology

    6.2. Product Adoption / Usage Analysis

    6.3. Promotional Strategies by Key Players

7. Global Respiratory Inhaler Devices Market Demand (in Volume ‘000 Units) Analysis 2015-2019 and Forecast, 2020–2030

    7.1. Historical Market Volume (‘000 Units) Analysis, 2015-2019

    7.2. Current and Future Market Volume (‘000 Units) Projections, 2020-2030

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute Units Opportunity Analysis

8. Global Respiratory Inhaler Devices Market - Pricing Analysis

    8.1. Regional Pricing Analysis, By Product Type

    8.2. Global Average Pricing Analysis Benchmark

9. Global Respiratory Inhaler Devices Market Demand (in Value or Size in US$ Mn) Analysis 2015-2019 and Forecast, 2020–2030

    9.1. Historical Market Value (US$ Mn) Analysis, 2015-2019

    9.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030

        9.2.1. Y-o-Y Growth Trend Analysis

        9.2.2. Absolute $ Opportunity Analysis

10. Global Respiratory Inhaler Devices Market  and Volume Analysis 2015-2019 and Forecast 2020-2030, By Product Type

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product Type, 2015 - 2019

    10.3. Current and Future Market Size (US$ Mn)  and Volume (Units) Analysis and Forecast By Product Type, 2020 – 2030

        10.3.1. Dry Powder Inhaler

        10.3.2. Metered Dose Inhaler

        10.3.3. Nebulizer

            10.3.3.1. Compressed Air Nebulizers

            10.3.3.2. Ultrasonic Nebulizers

            10.3.3.3. Mesh Nebulizers

    10.4. Market Attractiveness Analysis By Product Type

11. Global Respiratory Inhaler Devices Market Analysis 2015-2019 and Forecast 2020-2030, By Technology 

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Mn) Analysis By Technology, 2015 - 2019

    11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Technology, 2020 – 2030

        11.3.1. Manually Operated Inhaler Devices

        11.3.2. Digitally Operated Inhaler Devices

    11.4. Market Attractiveness Analysis By Technology

12. Global Respiratory Inhaler Devices Market Analysis 2015-2019 and Forecast 2020-2030, By Disease Indication

    12.1. Introduction / Key Findings

    12.2. Historical Market Size (US$ Mn) Analysis By Disease Indication, 2015 - 2019

    12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Disease Indication, 2020 – 2030

        12.3.1. Asthma

        12.3.2. COPD

        12.3.3. Pulmonary Arterial Hypertension

        12.3.4. Other Respiratory Diseases

    12.4. Market Attractiveness Analysis By Disease Indication

13. Global Respiratory Inhaler Devices Market Analysis 2015-2019 and Forecast 2020-2030, By Region

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) Analysis By Region, 2015 - 2019

    13.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2020 - 2030

        13.3.1. North America

        13.3.2. Latin America

        13.3.3. Europe

        13.3.4. East Asia

        13.3.5. South Asia

        13.3.6. Oceania

        13.3.7. Middle East and Africa (MEA)

    13.4. Market Attractiveness Analysis By Region

14. North America Respiratory Inhaler Devices Market Analysis 2015-2019 and Forecast 2020-2030

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2015 - 2019

    14.3. Market Size (US$ Mn) and Volume (Units)  Forecast By Market Taxonomy, 2020 - 2030

        14.3.1. By Country

            14.3.1.1. U.S.

            14.3.1.2. Canada

        14.3.2. By Product Type

        14.3.3. By Technology

        14.3.4. B Disease Indication

    14.4. Market Attractiveness Analysis

    14.5. Key Market Participants - Intensity Mapping

    14.6. Drivers and Restraints - Impact Analysis

15. Latin America Respiratory Inhaler Devices Market Analysis 2015-2019 and Forecast 2020-2030

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) and Volume (Units)  Trend Analysis By Market Taxonomy, 2015 - 2019

    15.3. Market Size (US$ Mn) and Volume (Units)  Forecast By Market Taxonomy, 2020 - 2030

        15.3.1. By Country

            15.3.1.1. Brazil

            15.3.1.2. Mexico

            15.3.1.3. Argentina

            15.3.1.4. Rest of Latin America

        15.3.2. By Product Type

        15.3.3. By Technology

        15.3.4. B Disease Indication

    15.4. Market Attractiveness Analysis

    15.5. Key Market Participants - Intensity Mapping

    15.6. Drivers and Restraints - Impact Analysis

16. Europe Respiratory Inhaler Devices Market Analysis 2015-2019 and Forecast 2020-2030

    16.1. Introduction

    16.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2015 - 2019

    16.3. Market Size (US$ Mn) and Volume (Units) Forecast By Market Taxonomy, 2020 - 2030

        16.3.1. By Country

            16.3.1.1. Germany

            16.3.1.2. Italy

            16.3.1.3. France

            16.3.1.4. U.K.

            16.3.1.5. Spain

            16.3.1.6. BENELUX

            16.3.1.7. Russia

            16.3.1.8. Rest of Europe

        16.3.2. By Product Type

        16.3.3. By Technology

        16.3.4. B Disease Indication

    16.4. Market Attractiveness Analysis

    16.5. Key Market Participants - Intensity Mapping

    16.6. Drivers and Restraints - Impact Analysis

17. South Asia Respiratory Inhaler Devices Market Analysis 2015-2019 and Forecast 2020-2030

    17.1. Introduction

    17.2. Historical Market Size (US$ Mn) and Volume (Units)  Trend Analysis By Market Taxonomy, 2015 - 2019

    17.3. Market Size (US$ Mn) and Volume (Units) Forecast By Market Taxonomy, 2020 - 2030

        17.3.1. By Country

            17.3.1.1. India

            17.3.1.2. Thailand

            17.3.1.3. Indonesia

            17.3.1.4. Malaysia

            17.3.1.5. Rest of South Asia

        17.3.2. By Product Type

        17.3.3. By Technology

        17.3.4. B Disease Indication

    17.4. Market Attractiveness Analysis

    17.5. Key Market Participants - Intensity Mapping

    17.6. Drivers and Restraints - Impact Analysis

18. East Asia Respiratory Inhaler Devices Market Analysis 2015-2019 and Forecast 2020-2030

    18.1. Introduction

    18.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2015 - 2019

    18.3. Market Size (US$ Mn) and Volume (Units)  Forecast By Market Taxonomy, 2020 - 2030

        18.3.1. By Country

            18.3.1.1. China

            18.3.1.2. Japan

            18.3.1.3. South Korea

        18.3.2. By Product Type

        18.3.3. By Technology

        18.3.4. B Disease Indication

    18.4. Market Attractiveness Analysis

    18.5. Key Market Participants - Intensity Mapping

    18.6. Drivers and Restraints - Impact Analysis

19. Oceania Respiratory Inhaler Devices Market Analysis 2015-2019 and Forecast 2020-2030

    19.1. Introduction

    19.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2015 - 2019

    19.3. Market Size (US$ Mn) and Volume (Units) Forecast By Market Taxonomy, 2020 - 2030

        19.3.1. By Country

            19.3.1.1. Australia

            19.3.1.2. New Zealand

        19.3.2. By Product Type

        19.3.3. By Technology

        19.3.4. B Disease Indication

    19.4. Market Attractiveness Analysis

    19.5. Key Market Participants - Intensity Mapping

    19.6. Drivers and Restraints - Impact Analysis

20. Middle East and Africa Respiratory Inhaler Devices Market Analysis 2015-2019 and Forecast 2020-2030

    20.1. Introduction

    20.2. Historical Market Size (US$ Mn) and Volume (Units)  Trend Analysis By Market Taxonomy, 2015 - 2019

    20.3. Market Size (US$ Mn) and Volume (Units)  Forecast By Market Taxonomy, 2020 - 2030

        20.3.1. By Country

            20.3.1.1. GCC Countries

            20.3.1.2. South Africa

            20.3.1.3. Rest of Middle East and Africa

        20.3.2. By Product Type

        20.3.3. By Technology

        20.3.4. By Disease Indication

    20.4. Market Attractiveness Analysis

    20.5. Key Market Participants - Intensity Mapping

    20.6. Drivers and Restraints - Impact Analysis

21. Key and Emerging Countries Respiratory Inhaler Devices Market Analysis 2015-2019 and Forecast 2020-2030

    21.1. Introduction

        21.1.1. Market Value Proportion Analysis, By Key Countries

        21.1.2. Global Vs. Country Growth Comparison

    21.2. U.S. Respiratory Inhaler Devices Market Analysis

        21.2.1. By Product Type

        21.2.2. By Technology

        21.2.3. B Disease Indication

    21.3. Canada Respiratory Inhaler Devices Market Analysis

        21.3.1. By Product Type

        21.3.2. By Technology

        21.3.3. By Disease Indication

    21.4. Mexico Respiratory Inhaler Devices Market Analysis

        21.4.1. By Product Type

        21.4.2. By Technology

        21.4.3. By Disease Indication

    21.5. Brazil Respiratory Inhaler Devices Market Analysis

        21.5.1. By Product Type

        21.5.2. By Technology

        21.5.3. By Disease Indication

    21.6. U.K. Respiratory Inhaler Devices Market Analysis

        21.6.1. By Product Type

        21.6.2. By Technology

        21.6.3. By Disease Indication

    21.7. Germany Respiratory Inhaler Devices Market Analysis

        21.7.1. By Product Type

        21.7.2. By Technology

        21.7.3. By Disease Indication

    21.8. France Respiratory Inhaler Devices Market Analysis

        21.8.1. By Product Type

        21.8.2. By Technology

        21.8.3. By Disease Indication

    21.9. Italy Respiratory Inhaler Devices Market Analysis

        21.9.1. By Product Type

        21.9.2. By Technology

        21.9.3. By Disease Indication

    21.10. Spain Respiratory Inhaler Devices Market Analysis

        21.10.1. By Product Type

        21.10.2. By Technology

        21.10.3. By Disease Indication

    21.11. BENELUX Respiratory Inhaler Devices Market Analysis

        21.11.1. By Product Type

        21.11.2. By Technology

        21.11.3. By Disease Indication

    21.12. Russia Respiratory Inhaler Devices Market Analysis

        21.12.1. By Product Type

        21.12.2. By Technology

        21.12.3. By Disease Indication

    21.13. China Respiratory Inhaler Devices Market Analysis

        21.13.1. By Product type

        21.13.2. By Technology

        21.13.3. By Disease Indication

    21.14. Japan Respiratory Inhaler Devices Market Analysis

        21.14.1. By Product Type

        21.14.2. By Technology

        21.14.3. By Disease Indication

    21.15. South Korea Respiratory Inhaler Devices Market Analysis

        21.15.1. By Product Type

        21.15.2. By Indication

        21.15.3. By End User

    21.16. India Respiratory Inhaler Devices Market Analysis

        21.16.1. By Product Type

        21.16.2. By Technology

        21.16.3. By Disease Indication

    21.17. ASEAN Respiratory Inhaler Devices Market Analysis

        21.17.1. By Product Type

        21.17.2. By Technology

        21.17.3. By Disease Indication

    21.18. Australia Respiratory Inhaler Devices Market Analysis

        21.18.1. By Product Type

        21.18.2. By Technology

        21.18.3. By Disease Indication

    21.19. New Zealand Respiratory Inhaler Devices Market Analysis

        21.19.1. By Product Type

        21.19.2. By Technology

        21.19.3. By Disease Indication

    21.20. GCC Countries Respiratory Inhaler Devices Market Analysis

        21.20.1. By Product Type

        21.20.2. By Technology

        21.20.3. By Disease Indication

    21.21. Turkey Respiratory Inhaler Devices Market Analysis

        21.21.1. By Product Type

        21.21.2. By Technology

        21.21.3. By Disease Indication

    21.22. South Africa Respiratory Inhaler Devices Market Analysis

        21.22.1. By Product Type

        21.22.2. By Technology

        21.22.3. By Disease Indication

22. Market Structure Analysis

    22.1. Market Analysis by Tier of Companies 

    22.2. Market Concentration

    22.3. Market Share Analysis of Top Players

    22.4. Market Presence Analysis

        22.4.1. By Regional Footprint of Players

        22.4.2. Product Footprint by Players

        22.4.3. Channel Footprint by Players

23. Competition Analysis

    23.1. Competition Dashboard

    23.2. Competition Benchmarking

    23.3. Competition Deep Dive (Tentative List)

        23.3.1. AstraZeneca

            23.3.1.1. Product Type Portfolio

            23.3.1.2. Profitability by Market Segments (Product Type/Technology/Region)

            23.3.1.3. Sales Footprint

            23.3.1.4. Analyst commentary

            23.3.1.5. Strategy Overview

            23.3.1.6. Marketing Strategy

            23.3.1.7. Treatment Type Strategy

            23.3.1.8. Channel Strategy

        23.3.2. Beximco Pharmaceuticals Ltd.

            23.3.2.1. Product Type Portfolio

            23.3.2.2. Profitability by Market Segments (Product Type/Technology/Region)

            23.3.2.3. Sales Footprint

            23.3.2.4. Analyst commentary

            23.3.2.5. Strategy Overview

            23.3.2.6. Marketing Strategy

            23.3.2.7. Treatment Type Strategy

            23.3.2.8. Channel Strategy

        23.3.3. Boehringer Ingelheim GmbH

            23.3.3.1. Product Type Portfolio

            23.3.3.2. Profitability by Market Segments (Product Type/Technology/Region)

            23.3.3.3. Sales Footprint

            23.3.3.4. Analyst commentary

            23.3.3.5. Strategy Overview

            23.3.3.6. Marketing Strategy

            23.3.3.7. Treatment Type Strategy

            23.3.3.8. Channel Strategy

        23.3.4. Cipla Ltd.

            23.3.4.1. Product Type Portfolio

            23.3.4.2. Profitability by Market Segments (Product Type/Technology/Region)

            23.3.4.3. Sales Footprint

            23.3.4.4. Analyst commentary

            23.3.4.5. Strategy Overview

            23.3.4.6. Marketing Strategy

            23.3.4.7. Treatment Type Strategy

            23.3.4.8. Channel Strategy

        23.3.5. GlaxoSmithKline plc.

            23.3.5.1. Product Type Portfolio

            23.3.5.2. Profitability by Market Segments (Product Type/Technology/Region)

            23.3.5.3. Sales Footprint

            23.3.5.4. Analyst commentary

            23.3.5.5. Strategy Overview

            23.3.5.6. Marketing Strategy

            23.3.5.7. Treatment Type Strategy

            23.3.5.8. Channel Strategy

        23.3.6. Koninklijke Philips N.V.

            23.3.6.1. Product Type Portfolio

            23.3.6.2. Profitability by Market Segments (Product Type/Technology/Region)

            23.3.6.3. Sales Footprint

            23.3.6.4. Analyst commentary

            23.3.6.5. Strategy Overview

            23.3.6.6. Marketing Strategy

            23.3.6.7. Treatment Type Strategy

            23.3.6.8. Channel Strategy

        23.3.7. Merck & Co., Inc.

            23.3.7.1. Product Type Portfolio

            23.3.7.2. Profitability by Market Segments (Product Type/Technology/Region)

            23.3.7.3. Sales Footprint

            23.3.7.4. Analyst commentary

            23.3.7.5. Strategy Overview

            23.3.7.6. Marketing Strategy

            23.3.7.7. Treatment Type Strategy

            23.3.7.8. Channel Strategy

        23.3.8. OMRON Healthcare Europe B.V.

            23.3.8.1. Product Type Portfolio

            23.3.8.2. Profitability by Market Segments (Product Type/Technology/Region)

            23.3.8.3. Sales Footprint

            23.3.8.4. Analyst commentary

            23.3.8.5. Strategy Overview

            23.3.8.6. Marketing Strategy

            23.3.8.7. Treatment Type Strategy

            23.3.8.8. Channel Strategy

        23.3.9. PARI Medical Holding

            23.3.9.1. Product Type Portfolio

            23.3.9.2. Profitability by Market Segments (Product Type/Technology/Region)

            23.3.9.3. Sales Footprint

            23.3.9.4. Analyst commentary

            23.3.9.5. Strategy Overview

            23.3.9.6. Marketing Strategy

            23.3.9.7. Treatment Type Strategy

            23.3.9.8. Channel Strategy

        23.3.10. Teva Pharmaceutical Industries Ltd.

            23.3.10.1. Product Type Portfolio

            23.3.10.2. Profitability by Market Segments (Product Type/Technology/Region)

            23.3.10.3. Sales Footprint

            23.3.10.4. Analyst commentary

            23.3.10.5. Strategy Overview

            23.3.10.6. Marketing Strategy

            23.3.10.7. Treatment Type Strategy

            23.3.10.8. Channel Strategy

24. Assumptions and Acronyms Used

25. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Global Respiratory Inhaler Devices Market Valve (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030,By Product Type

Table 02: Global Respiratory Inhaler Devices Volume ('000 Units) Analysis 2015–2019 and Forecast 2020–2030, By Product Type

Table 03: Global Respiratory Inhaler Devices Market Valve (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030,By Technology

Table 04: Global Respiratory Inhaler Devices Market Valve (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030,By Disease Indication

Table 05: Global Respiratory Inhaler Devices Market Valve (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030,By Region

Table 06: North America Respiratory Inhaler Devices Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Country

Table 07: North America Respiratory Inhaler Devices Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Product Type

Table 08: North America Respiratory Inhaler Devices Market Volume ('000 Units) Analysis 2015–2019 and Forecast 2020–2030, By Product Type

Table 09: North America Respiratory Inhaler Devices Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030 , By Technology

Table 10: North America Respiratory Inhaler Devices Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Disease Indication

Table 11: Latin America Respiratory Inhaler Devices Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Country

Table 12: Latin America Respiratory Inhaler Devices Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Product Type

Table 13: Latin America Respiratory Inhaler Devices Market Volume ('000 Units) Analysis 2015–2019 and Forecast 2020–2030, By Product Type

Table 14: Latin America Respiratory Inhaler Devices Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030 , By Technology

Table 15: Latin America Respiratory Inhaler Devices Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Disease Indication

Table 16: Europe Respiratory Inhaler Devices Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030,By Country

Table 17: Europe Respiratory Inhaler Devices Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Product Type

Table 18: Europe Respiratory Inhaler Devices Market Volume ('000 Units) Analysis 2015–2019 and Forecast 2020–2030, By Product Type

Table 19: Europe Respiratory Inhaler Devices Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030 , By Technology

Table 20: Europe Respiratory Inhaler Devices Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Disease Indication

Table 21: South Asia Respiratory Inhaler Devices Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Country

Table 22: South Asia Respiratory Inhaler Devices Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Product Type

Table 23: South Asia Respiratory Inhaler Devices Market Volume ('000 Units) Analysis 2015–2019 and Forecast 2020–2030, By Product Type

Table 24: South Asia Respiratory Inhaler Devices Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030 , By Technology

Table 25: South Asia Respiratory Inhaler Devices Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Disease Indication

Table 26: East Asia Respiratory Inhaler Devices Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Country

Table 27: East Asia Respiratory Inhaler Devices Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Product Type

Table 28: East Asia Respiratory Inhaler Devices Market Volume ('000 Units) Analysis 2015–2019 and Forecast 2020–2030, By Product Type

Table 29: East Asia Respiratory Inhaler Devices Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030 , By Technology

Table 30: East Asia Respiratory Inhaler Devices Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Disease Indication

Table 31: Oceania Respiratory Inhaler Devices Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Country

Table 32: Oceania Respiratory Inhaler Devices Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Product Type

Table 33: Oceania Respiratory Inhaler Devices Market Volume ('000 Units) Analysis 2014–2018 and Forecast 2019–2029, By Product Type

Table 34: Oceania Respiratory Inhaler Devices Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030 , By Technology

Table 35: Oceania Respiratory Inhaler Devices Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Disease Indication

Table 36: Middle East and Africa Respiratory Inhaler Devices Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Country

Table 37: Middle East and Africa Respiratory Inhaler Devices Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Product Type

Table 38: Middle East and Africa Respiratory Inhaler Devices Market Volume ('000 Units) Analysis 2015–2019 and Forecast 2020–2030, By Product Type

Table 39: Middle East and Africa Respiratory Inhaler Devices Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030 , By Technology

Table 40: Middle East and Africa Respiratory Inhaler Devices Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Disease Indication

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Global Respiratory Inhaler Devices Market Value Share by Product Type (2020 A)

Figure 02: Global Respiratory Inhaler Devices Market Value Share by Technology (2020 A)

Figure 03: Global Respiratory Inhaler Devices Market Value Share by Disease Indication (2020 A)

Figure 04: Global Respiratory Inhaler Devices Market Value Share by Country (2020 A)

Figure 05: Global Respiratory Inhaler Devices Market Historical Market Value and Y-o-Y, 2015-2019

Figure 06: Global Respiratory Inhaler Devices Market Value (US$ Mn) & Y-o-Y Growth (%), 2019–2030

Figure 07: Global Respiratory Inhaler Devices Market Absolute $ Opportunity, 2020 –2030

Figure 08: Global Dry Powder Inhaler, Price Difference (US$) By Region, 2019

Figure 09: Global Dry Powder Inhaler, Price Difference (US$) By Region, 2030

Figure 10: Global Metered Dose Inhaler, Price Difference (US$) By Region, 2019

Figure 11: Global Metered Dose Inhaler, Price Difference (US$) By Region, 2030

Figure 12: Global Ultrasonic Nebulizer, Price Difference (US$) By Region, 2019

Figure 13: Global Ultrasonic Nebulizer, Price Difference (US$) By Region, 2030

Figure 14: Global Compressed Air Nebulizer, Price Difference (US$) By Region, 2019

Figure 15: Global Compressed Air Nebulizer, Price Difference (US$) By Region, 2030

Figure 16: Global Mesh Nebulizer, Price Difference (US$) By Region, 2019

Figure 17: Global Mesh Nebulizer, Price Difference (US$) By Region, 2030

Figure 18: Global Respiratory Inhaler Devices Market Historical Market Value and Y-o-Y, 2015-2019

Figure 19: Global Respiratory Inhaler Devices Market Value (US$ Mn) & Y-o-Y Growth (%), 2019–2030

Figure 20: Global Respiratory Inhaler Devices Market Absolute $ Opportunity, 2020 –2030

Figure 21: Global Respiratory Inhaler Devices Market Share Analysis (%) by Product Type, 2020 & 2030

Figure 22: Global Respiratory Inhaler Devices Market Y-o-Y Growth (%) by Product Type, 2021–2030

Figure 23: Global Respiratory Inhaler Devices Market Attractiveness Analysis, By Product Type

Figure 24: Global Respiratory Inhaler Devices Market Share Analysis (%) by Technology, 2020 & 2030

Figure 25: Global Respiratory Inhaler Devices Market Y-o-Y Growth (%) by Technology, 2021–2030

Figure 26: Global Respiratory Inhaler Devices Market Attractiveness Analysis, By Technology

Figure 27: Global Respiratory Inhaler Devices Market Share Analysis (%) by Disease Indication, 2020 & 2030

Figure 28: Global Respiratory Inhaler Devices Market Y-o-Y Growth (%) by Disease Indication, 2021–2030

Figure 29: Global Respiratory Inhaler Devices Market Attractiveness Analysis, By Disease Indication

Figure 30: Global Respiratory Inhaler Devices Market Share Analysis (%) by Region, 2020 & 2030

Figure 31: Global Respiratory Inhaler Devices  Market Y-o-Y Growth (%) by region, 2021–2030

Figure 32: Global Respiratory Inhaler Devices Market Attractiveness Analysis, By Region

Figure 33: North America Respiratory Inhaler Devices Market Volume (In '000 Units) Analysis 2020E & 2020F,Product Type

Figure 34: North America Respiratory Inhaler Devices Market Value Share Analysis 2020E, By Country

Figure 35: North America Respiratory Inhaler Devices Market Value (US$ Mn) Analysis, 2015–2019

Figure 36: North America Respiratory Inhaler Devices Market Forecast & Y-o-Y growth, 2020–2030 

Figure 37: North America Respiratory Inhaler Devices Market Attractiveness Analysis 2020-2030, By Product Type 

Figure 38: North America Respiratory Inhaler Devices Market Attractiveness Analysis 2020-2030, By Technology

Figure 39: North America Respiratory Inhaler Devices Market Attractiveness Analysis 2020-2030, By Disease Indication

Figure 40: North America Respiratory Inhaler Devices Market Attractiveness Analysis 2020-2030, By Country

Figure 41: Latin America Respiratory Inhaler Devices Market Volume (In '000 Units) Analysis 2020E & 2030F,Product Type

Figure 42: Latin America Respiratory Inhaler Devices Market Value Share Analysis 2020E, By Country

Figure 43: Latin America Respiratory Inhaler Devices Market Value (US$ Mn) Analysis, 2015–2019

Figure 44: Latin America Respiratory Inhaler Devices Market Forecast & Y-o-Y growth, 2020–2030

Figure 45: Latin America Respiratory Inhaler Devices Market Attractiveness Analysis 2020-2030, By Product Type

Figure 46: Latin America Respiratory Inhaler Devices Market Attractiveness Analysis 2020-2030, By Technology

Figure 47: Latin America Respiratory Inhaler Devices Market Attractiveness Analysis, By Disease Indication

Figure 48: Latin America Respiratory Inhaler Devices Market Attractiveness Analysis, By Country

Figure 49: Europe Respiratory Inhaler Devices Market Volume (In '000 Units) Analysis 2020E & 2030E, Product Type

Figure 50: Europe Respiratory Inhaler Devices Market Value Share Analysis 2020E, By Country

Figure 51: Europe Respiratory Inhaler Devices Market Value (US$ Mn) Analysis, 2015–2019

Figure 52: Europe Respiratory Inhaler Devices Market Forecast & Y-o-Y growth, 2020–2030

Figure 53: Europe Respiratory Inhaler Devices Market Attractiveness Analysis 2020-2030, By Product Type

Figure 54: Europe Respiratory Inhaler Devices Market Attractiveness Analysis 2020-2030, By Technology

Figure 55: Europe Respiratory Inhaler Devices Market Attractiveness Analysis 2020-2030, By Disease Indication

Figure 56: Western Europe Respiratory Inhaler Devices Market Attractiveness Analysis 2020-2030, By Country

Figure 57: South Asia Respiratory Inhaler Devices Market Volume (In '000 Units) Analysis 2020E & 2030F, Product Type

Figure 58: South Asia Respiratory Inhaler Devices Market Value Share Analysis 2020E, By Country

Figure 59: South Asia Respiratory Inhaler Devices Market Value (US$ Mn) Analysis, 2015–2019

Figure 60: South Asia Respiratory Inhaler Devices Market Forecast & Y-o-Y growth, 2020–2030

Figure 61: South Asia Respiratory Inhaler Devices Market Attractiveness Analysis 2020-2030, By Product Type

Figure 62: South Asia Respiratory Inhaler Devices Market Attractiveness Analysis 2020-2030, By Technology

Figure 63: South Asia Excluding India & Japan Respiratory Inhaler Devices Market Attractiveness Analysis 2020-2030, By Disease Indication

Figure 64: South Asia Excluding India & Japan Respiratory Inhaler Devices Market Attractiveness Analysis 2020-2030, By Country

Figure 65: East Asia Respiratory Inhaler Devices Market Volume (In '000 Units) Analysis 2020E & 2030F,Product Type

Figure 66: East Asia Europe Respiratory Inhaler Devices Market Value Share Analysis 2020E, By Country

Figure 67: East Asia Respiratory Inhaler Devices Market Value (US$ Mn) Analysis, 2015–2019

Figure 68: East Asia Respiratory Inhaler Devices Market Forecast & Y-o-Y growth, 2020–2030

Figure 69: East Asia Respiratory Inhaler Devices Market Attractiveness Analysis 2020-2030, By Product Type

Figure 70: East Asia Respiratory Inhaler Devices Market Attractiveness Analysis 2020-2030, By Technology

Figure 71: East Asia Respiratory Inhaler Devices Market Attractiveness Analysis, By Disease Indication

Figure 72: East Asia Respiratory Inhaler Devices Market Attractiveness Analysis, By Country

Figure 73: Oceania Respiratory Inhaler Devices Market Volume (In '000 Units) Analysis 2020E & 2030F,Product Type

Figure 74: Oceania Respiratory Inhaler Devices Market Volume (In '000 Units) Analysis, 2020E & 2030F

Figure 75: Oceania Respiratory Inhaler Devices Market Value (US$ Mn) Analysis, 2015–2019

Figure 76: Oceania Respiratory Inhaler Devices Market Forecast & Y-o-Y growth, 2020–2030

Figure 77: Oceania Respiratory Inhaler Devices Market Attractiveness Analysis 2020-2030, By Product Type

Figure 78: Oceania Respiratory Inhaler Devices Market Attractiveness Analysis 2020-2030, By Technology

Figure 79: Oceania Respiratory Inhaler Devices Market Attractiveness Analysis 2020-2030, By Disease Indication

Figure 80: Oceania Respiratory Inhaler Devices Market Attractiveness Analysis 2020-2030, By Country

Figure 81: Middle East & Africa Respiratory Inhaler Devices Market Volume (In '000 Units) Analysis 2020E & 2030F,Product Type

Figure 82: Middle East & Africa Respiratory Inhaler Devices Market Value Share Analysis 2020E, By Country

Figure 83: Middle East and Africa Respiratory Inhaler Devices Market Value (US$ Mn) Analysis, 2015–2019

Figure 84: Middle East and Africa Respiratory Inhaler Devices Market Forecast & Y-o-Y growth, 2020–2030

Figure 85: Middle East and Africa Respiratory Inhaler Devices Market Attractiveness Analysis 2020-2030,By Product Type

Figure 86: Middle East and Africa Respiratory Inhaler Devices Market Attractiveness Analysis 2020-2030,By Technology

Figure 87: Middle East & Africa Respiratory Inhaler Devices Market Attractiveness Analysis 2020-2030,By Disease Indication

Figure 88: Middle East & Africa Respiratory Inhaler Devices Market Attractiveness Analysis 2020-2030, By Country

Figure 89 : U.S. Respiratory Inhaler Devices Market Share Analysis (%), by Product in Volume, 2020 & 2030

Figure 90: U.S. Respiratory Inhaler Devices Market Share Analysis (%), by Technology , 2020 & 2030

Figure 91: U.S. Respiratory Inhaler Devices Market Share Analysis (%), by Indication, 2020 & 2030

Figure 92: U.S. Respiratory Inhaler Devices Market Value Analysis (US$ Mn), 2020 & 2030

Figure 93 : Canada Respiratory Inhaler Devices Market Share Analysis (%), by Product in Volume, 2020 & 2030

Figure 94: Canada Respiratory Inhaler Devices Market Share Analysis (%), by Technology , 2020 & 2030

Figure 95: Canada Respiratory Inhaler Devices Market Share Analysis (%), by Indication, 2020 & 2030

Figure 96: Canada Respiratory Inhaler Devices Market Value Analysis (US$ Mn), 2020 & 2030

Figure 97 : Argentina Respiratory Inhaler Devices Market Share Analysis (%), by Product in Volume, 2020 & 2030

Figure 98: Argentina Respiratory Inhaler Devices Market Share Analysis (%), by Technology , 2020 & 2030

Figure 99: Argentina Respiratory Inhaler Devices Market Share Analysis (%), by Indication, 2020 & 2030

Figure 100: Argentina Respiratory Inhaler Devices Market Value Analysis (US$ Mn), 2020 & 2030

Figure 101 : Mexico Respiratory Inhaler Devices Market Share Analysis (%), by Product in Volume, 2020 & 2030

Figure 102: Mexico Respiratory Inhaler Devices Market Share Analysis (%), by Technology , 2020 & 2030

Figure 103: Mexico Respiratory Inhaler Devices Market Share Analysis (%), by Indication, 2020 & 2030

Figure 104: Mexico Respiratory Inhaler Devices Market Value Analysis (US$ Mn), 2020 & 2030

Figure 105 : Brazil Respiratory Inhaler Devices Market Share Analysis (%), by Product in Volume, 2020 & 2030

Figure 106: Brazil Respiratory Inhaler Devices Market Share Analysis (%), by Technology , 2020 & 2030

Figure 107: Brazil Respiratory Inhaler Devices Market Share Analysis (%), by Indication, 2020 & 2030

Figure 108: Brazil Respiratory Inhaler Devices Market Value Analysis (US$ Mn), 2020 & 2030

Figure 109 : UK Respiratory Inhaler Devices Market Share Analysis (%), by Product in Volume, 2020 & 2030

Figure 110: UK Respiratory Inhaler Devices Market Share Analysis (%), by Technology , 2020 & 2030

Figure 111: UK Respiratory Inhaler Devices Market Share Analysis (%), by Indication, 2020 & 2030

Figure 112: UK Respiratory Inhaler Devices Market Value Analysis (US$ Mn), 2020 & 2030

Figure 113 : Germany Respiratory Inhaler Devices Market Share Analysis (%), by Product in Volume, 2020 & 2030

Figure 114: Germany Respiratory Inhaler Devices Market Share Analysis (%), by Technology , 2020 & 2030

Figure 115: Germany Respiratory Inhaler Devices Market Share Analysis (%), by Indication, 2020 & 2030

Figure 116: Germany Respiratory Inhaler Devices Market Value Analysis (US$ Mn), 2020 & 2030

Figure 117 : France Respiratory Inhaler Devices Market Share Analysis (%), by Product in Volume, 2020 & 2030

Figure 118: France Respiratory Inhaler Devices Market Share Analysis (%), by Technology , 2020 & 2030

Figure 119: France Respiratory Inhaler Devices Market Share Analysis (%), by Indication, 2020 & 2030

Figure 120: France Respiratory Inhaler Devices Market Value Analysis (US$ Mn), 2020 & 2030

Figure 121 : Spain Respiratory Inhaler Devices Market Share Analysis (%), by Product in Volume, 2020 & 2030

Figure 122: Spain Respiratory Inhaler Devices Market Share Analysis (%), by Technology , 2020 & 2030

Figure 123: Spain Respiratory Inhaler Devices Market Share Analysis (%), by Indication, 2020 & 2030

Figure 124: Spain Respiratory Inhaler Devices Market Value Analysis (US$ Mn), 2020 & 2030

Figure 125 : Italy Respiratory Inhaler Devices Market Share Analysis (%), by Product in Volume, 2020 & 2030

Figure 126: Italy Respiratory Inhaler Devices Market Share Analysis (%), by Technology , 2020 & 2030

Figure 127: Italy Respiratory Inhaler Devices Market Share Analysis (%), by Indication, 2020 & 2030

Figure 128: Italy Respiratory Inhaler Devices Market Value Analysis (US$ Mn), 2020 & 2030

Figure 129 : Russia Respiratory Inhaler Devices Market Share Analysis (%), by Product in Volume, 2020 & 2030

Figure 130: Russia Respiratory Inhaler Devices Market Share Analysis (%), by Technology , 2020 & 2030

Figure 131: Russia Respiratory Inhaler Devices Market Share Analysis (%), by Indication, 2020 & 2030

Figure 132: Russia Respiratory Inhaler Devices Market Value Analysis (US$ Mn), 2020 & 2030

Figure 133 : Benelux Respiratory Inhaler Devices Market Share Analysis (%), by Product in Volume, 2020 & 2030

Figure 134: Benelux Respiratory Inhaler Devices Market Share Analysis (%), by Technology , 2020 & 2030

Figure 135: Benelux Respiratory Inhaler Devices Market Share Analysis (%), by Indication, 2020 & 2030

Figure 136: Benelux Respiratory Inhaler Devices Market Value Analysis (US$ Mn), 2020 & 2030

Figure 137 : China Respiratory Inhaler Devices Market Share Analysis (%), by Product in Volume, 2020 & 2030

Figure 138: China Respiratory Inhaler Devices Market Share Analysis (%), by Technology , 2020 & 2030

Figure 139: China Respiratory Inhaler Devices Market Share Analysis (%), by Indication, 2020 & 2030

Figure 140: China Respiratory Inhaler Devices Market Value Analysis (US$ Mn), 2020 & 2030

Figure 141 : Japan Respiratory Inhaler Devices Market Share Analysis (%), by Product in Volume, 2020 & 2030

Figure 142: Japan Respiratory Inhaler Devices Market Share Analysis (%), by Technology , 2020 & 2030

Figure 143: Japan Respiratory Inhaler Devices Market Share Analysis (%), by Indication, 2020 & 2030

Figure 144: Japan Respiratory Inhaler Devices Market Value Analysis (US$ Mn), 2020 & 2030

Figure 145 : South Korea Respiratory Inhaler Devices Market Share Analysis (%), by Product in Volume,2020 & 2030

Figure 146: South Korea Respiratory Inhaler Devices Market Share Analysis (%), by Technology , 2020 & 2030

Figure 147: South Korea Respiratory Inhaler Devices Market Share Analysis (%), by Indication, 2020 & 2030

Figure 148: South Korea Respiratory Inhaler Devices Market Value Analysis (US$ Mn), 2020 & 2030

Figure 149 : Thailand Respiratory Inhaler Devices Market Share Analysis (%), by Product in Volume, 2020 & 2030

Figure 150: Thailand Respiratory Inhaler Devices Market Share Analysis (%), by Technology , 2020 & 2030

Figure 151: Thailand Respiratory Inhaler Devices Market Share Analysis (%), by Indication, 2020 & 2030

Figure 152: Thailand Respiratory Inhaler Devices Market Value Analysis (US$ Mn), 2020 & 2030

Figure 153 : Malaysia Respiratory Inhaler Devices Market Share Analysis (%), by Product in Volume, 2020 & 2030

Figure 154: Malaysia Respiratory Inhaler Devices Market Share Analysis (%), by Technology , 2020 & 2030

Figure 155: Malaysia Respiratory Inhaler Devices Market Share Analysis (%), by Indication, 2020 & 2030

Figure 156: Malaysia Respiratory Inhaler Devices Market Value Analysis (US$ Mn), 2020 & 2030

Figure 157 : India Respiratory Inhaler Devices Market Share Analysis (%), by Product in Volume, 2020 & 2030

Figure 158: India Respiratory Inhaler Devices Market Share Analysis (%), by Technology , 2020 & 2030

Figure 159: India Respiratory Inhaler Devices Market Share Analysis (%), by Indication, 2020 & 2030

Figure 160: India Respiratory Inhaler Devices Market Value Analysis (US$ Mn), 2020 & 2030

Figure 161 : Indonesia Respiratory Inhaler Devices Market Share Analysis (%), by Product in Volume, 2020 & 2030

Figure 162: Indonesia Respiratory Inhaler Devices Market Share Analysis (%), by Technology , 2020 & 2030

Figure 163: Indonesia Respiratory Inhaler Devices Market Share Analysis (%), by Indication, 2020 & 2030

Figure 164: Indonesia Respiratory Inhaler Devices Market Value Analysis (US$ Mn), 2020 & 2030

Figure 165: Australia Respiratory Inhaler Devices Market Share Analysis (%), by Product in Value, 2020 & 2030

Figure 166 : Australia Respiratory Inhaler Devices Market Share Analysis (%), by Product in Volume, 2020 & 2030

Figure 167: Australia Respiratory Inhaler Devices Market Share Analysis (%), by Technology , 2020 & 2030

Figure 168: Australia Respiratory Inhaler Devices Market Share Analysis (%), by Indication, 2020 & 2030

Figure 169: Australia Respiratory Inhaler Devices Market Value Analysis (US$ Mn), 2020 & 2030

Figure 170: New Zealand Respiratory Inhaler Devices Market Share Analysis (%), by Product in Value, 2020 & 2030

Figure 171: New Zealand Respiratory Inhaler Devices Market Share Analysis (%), by Product in Volume,2020 & 2030

Figure 172: New Zealand Respiratory Inhaler Devices Market Share Analysis (%), by Technology , 2020 & 2030

Figure 173: New Zealand Respiratory Inhaler Devices Market Share Analysis (%), by Indication, 2020 & 2030

Figure 174: New Zealand Respiratory Inhaler Devices Market Value Analysis (US$ Mn), 2020 & 2030

Figure 175: GCC Countries Respiratory Inhaler Devices Market Share Analysis (%), by Product in Value, 2020 & 2030

Figure 176 : GCC Countries Respiratory Inhaler Devices Market Share Analysis (%), by Product in Volume,2020 & 2030

Figure 177: GCC Countries Respiratory Inhaler Devices Market Share Analysis (%), by Technology , 2020 & 2030

Figure 178: GCC Countries Respiratory Inhaler Devices Market Share Analysis (%), by Indication, 2020 & 2030

Figure 179: GCC Countries Respiratory Inhaler Devices Market Value Analysis (US$ Mn), 2020 & 2030

Figure 180: North Africa Respiratory Inhaler Devices Market Share Analysis (%), by Product in Value, 2020 & 2030

Figure 181 : North Africa Respiratory Inhaler Devices Market Share Analysis (%), by Product in Volume,2020 & 2030

Figure 182: North Africa Respiratory Inhaler Devices Market Share Analysis (%), by Technology , 2020 & 2030

Figure 183: North Africa Respiratory Inhaler Devices Market Share Analysis (%), by Indication, 2020 & 2030

Figure 184: North Africa Respiratory Inhaler Devices Market Value Analysis (US$ Mn), 2020 & 2030

Figure 185: South Africa Respiratory Inhaler Devices Market Share Analysis (%), by Product in Value, 2020 & 2030

Figure 186: South Africa Respiratory Inhaler Devices Market Share Analysis (%), by Product in Volume,2020 & 2030

Figure 187: South Africa Respiratory Inhaler Devices Market Share Analysis (%), by Technology , 2020 & 2030

Figure 188: South Africa Respiratory Inhaler Devices Market Share Analysis (%), by Indication, 2020 & 2030

Figure 189: South Africa Respiratory Inhaler Devices Market Value Analysis (US$ Mn), 2020 & 2030

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports
Google translate

Respiratory Inhaler Devices Market